Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-07-29 00:51 | 2016-07-26 | PTHN | N/A | JLL Associates G.P. V (Patheon), Ltd. | 10% owner | Other | BUY | $19.85 | 815,730 | $16,188,162 | 40,287 | +100.0% |
| 2016-07-28 15:30 | 2016-07-26 | MFRM | N/A | 40 North Latitude Fund LP | 10% owner | Other | BUY | $29.81 | 401,775 | $11,978,319 | 1,966,502 | +25.7% |
| 2016-07-28 23:45 | 2016-07-26 | GE | GENERAL ELECTRIC CO | IMMELT JEFFREY R | Director, Officer - Chairman and CEO | Electronic & Other Electrical Equipment (No Computer Equip) | BUY | $31.45 | 50,000 | $1,572,500 | 2,198,688 | +2.3% |
| 2016-07-29 01:01 | 2016-07-26 | SLG | SL GREEN REALTY CORP | HOLLIDAY MARC | Director, Officer - Chief Executive Officer | Real Estate Investment Trusts | BUY | $26.84 | 37,340 | $1,002,206 | 51,560 | +262.6% |
| 2016-07-28 23:48 | 2016-07-26 | FMSA | N/A | Fowler Charles D. | Director | Other | BUY | $5.95 | 1,666,666 | $9,916,663 | 1,705,132 | +4,332.8% |
| 2016-07-27 23:30 | 2016-07-25 | ABT | Abbott Laboratories | WHITE MILES D | Director, Officer - Chairman and CEO | Pharmaceutical Preparations | BUY | $43.26 | 176,804 | $7,648,824 | 2,724,084 | +6.9% |
| 2016-07-27 23:29 | 2016-07-25 | ABT | Abbott Laboratories | WHITE MILES D | Director, Officer - Chairman and CEO | Pharmaceutical Preparations | BUY | $43.34 | 112,953 | $4,895,214 | 2,547,280 | +4.6% |
| 2016-07-27 23:29 | 2016-07-25 | ABT | Abbott Laboratories | WHITE MILES D | Director, Officer - Chairman and CEO | Pharmaceutical Preparations | BUY | $43.19 | 181,263 | $7,828,622 | 2,434,327 | +8.0% |
| 2016-07-27 23:27 | 2016-07-25 | ABT | Abbott Laboratories | WHITE MILES D | Director, Officer - Chairman and CEO | Pharmaceutical Preparations | BUY | $43.18 | 242,547 | $10,472,937 | 2,253,064 | +12.1% |
| 2016-07-26 18:34 | 2016-07-22 | DNP | DNP SELECT INCOME FUND INC | AMERICAN INTERNATIONAL GROUP INC | Other | Other | BUY | $42,961,538.46 | 52,000,000 | $2,233,999,999,998,000 | 0 | +100.0% |
| 2016-07-26 18:33 | 2016-07-22 | DNP | DNP SELECT INCOME FUND INC | AMERICAN HOME ASSURANCE CO | Other | Other | BUY | $4,660,000.00 | 4,660,000 | $21,715,600,000,000 | 0 | +100.0% |
| 2016-07-26 18:32 | 2016-07-22 | DNP | DNP SELECT INCOME FUND INC | AMERICAN GENERAL LIFE INSURANCE CO | Other | Other | BUY | $15,000,000.00 | 15,000,000 | $225,000,000,000,000 | 0 | +100.0% |
| 2016-07-26 18:10 | 2016-07-22 | AERI | N/A | Foresite Capital Management II, LLC | 10% owner | Other | BUY | $17.50 | 250,000 | $4,375,000 | 1,697,884 | +17.3% |
| 2016-07-26 00:06 | 2016-07-25 | BOLD | N/A | 5AM Partners III, LLC | 10% owner | Other | BUY | $15.00 | 70,000 | $1,050,000 | 60,100 | +100.0% |
| 2016-07-26 00:55 | 2016-07-22 | BK | Bank of New York Mellon Corp | GARDEN EDWARD P | Director | State Commercial Banks | BUY | $38.87 | 152,000 | $5,907,997 | 32,366,329 | +0.5% |
| 2016-07-26 02:54 | 2016-07-21 | NFLX | NETFLIX INC | HOAG JAY C | Director | Services-Video Tape Rental | BUY | $86.43 | 600,000 | $51,857,760 | 31,389 | +100.0% |
| 2016-07-25 19:19 | 2016-07-25 | BOLD | N/A | Flynn James E | 10% owner, Other | Other | BUY | $15.00 | 400,000 | $6,000,000 | 514,424 | +349.6% |
| 2016-07-22 00:13 | 2016-07-19 | LMB | Limbach Holdings, Inc. | 1347 Investors LLC | 10% owner | Construction - Special Trade Contractors | BUY | $10.00 | 1,333,314 | $13,333,140 | 2,581,314 | +106.8% |
| 2016-07-22 01:01 | 2016-07-19 | MFRM | N/A | 40 North Latitude Fund LP | 10% owner | Other | BUY | $30.64 | 78,310 | $2,399,418 | 1,564,727 | +5.3% |
| 2016-07-21 19:37 | 2016-06-02 | N/A | N/A | SBI Holdings, Inc. | 10% owner | Other | BUY | $14.98 | 6,472,500 | $96,941,869 | 8,028,056 | +416.1% |
| 2016-07-21 18:31 | 2016-07-19 | RILY | BRC Group Holdings, Inc. | ASHER DANIEL | 10% owner | Investment Advice | BUY | $9.10 | 149,700 | $1,362,270 | 2,356,901 | +6.8% |
| 2016-07-20 23:44 | 2016-07-18 | ARDX | Ardelyx Inc. | Viswanathan Ravi | 10% owner | Pharmaceutical Preparations | BUY | $8.73 | 1,527,301 | $13,333,338 | 2,665,519 | +134.2% |
| 2016-07-20 23:43 | 2016-07-18 | ARDX | Ardelyx Inc. | Sonsini Peter W. | 10% owner | Pharmaceutical Preparations | BUY | $8.73 | 1,527,301 | $13,333,338 | 2,665,519 | +134.2% |
| 2016-07-20 23:42 | 2016-07-18 | ARDX | Ardelyx Inc. | Sakoda Jon | 10% owner | Pharmaceutical Preparations | BUY | $8.73 | 1,527,301 | $13,333,338 | 2,665,519 | +134.2% |
| 2016-07-20 23:39 | 2016-07-18 | ARDX | Ardelyx Inc. | Florence Anthony A. Jr. | 10% owner | Pharmaceutical Preparations | BUY | $8.73 | 1,527,301 | $13,333,338 | 2,665,519 | +134.2% |
| 2016-07-20 23:36 | 2016-07-18 | ARDX | Ardelyx Inc. | NEA 15 GP, LLC | 10% owner | Pharmaceutical Preparations | BUY | $8.73 | 1,527,301 | $13,333,338 | 2,665,519 | +134.2% |
| 2016-07-20 23:37 | 2016-07-18 | ARDX | Ardelyx Inc. | New Enterprise Associates 12, Limited Partnership | 10% owner | Pharmaceutical Preparations | BUY | $8.73 | 763,650 | $6,666,665 | 8,752,543 | +9.6% |
| 2016-07-20 23:45 | 2016-07-18 | ARDX | Ardelyx Inc. | Weller Harry R | 10% owner | Pharmaceutical Preparations | BUY | $8.73 | 1,527,301 | $13,333,338 | 2,665,519 | +134.2% |
| 2016-07-20 23:39 | 2016-07-18 | ARDX | Ardelyx Inc. | BASKETT FOREST | 10% owner | Pharmaceutical Preparations | BUY | $8.73 | 2,290,951 | $20,000,002 | 2,665,519 | +611.6% |
| 2016-07-20 23:40 | 2016-07-18 | ARDX | Ardelyx Inc. | KOLLURI KRISHNA KITTU | 10% owner | Pharmaceutical Preparations | BUY | $8.73 | 2,290,951 | $20,000,002 | 2,665,519 | +611.6% |
| 2016-07-20 23:43 | 2016-07-18 | ARDX | Ardelyx Inc. | SANDELL SCOTT D | 10% owner | Pharmaceutical Preparations | BUY | $8.73 | 2,290,951 | $20,000,002 | 2,665,519 | +611.6% |
| 2016-07-20 23:41 | 2016-07-18 | ARDX | Ardelyx Inc. | MAKOWER JOSHUA | 10% owner | Pharmaceutical Preparations | BUY | $8.73 | 1,527,301 | $13,333,338 | 2,665,519 | +134.2% |
| 2016-07-20 23:40 | 2016-07-18 | ARDX | Ardelyx Inc. | KERINS PATRICK J | 10% owner | Pharmaceutical Preparations | BUY | $8.73 | 763,650 | $6,666,665 | 8,752,543 | +9.6% |
| 2016-07-20 23:42 | 2016-07-18 | ARDX | Ardelyx Inc. | MOTT DAVID M | Director, 10% owner | Pharmaceutical Preparations | BUY | $8.73 | 1,527,301 | $13,333,338 | 2,665,519 | +134.2% |
| 2016-07-20 23:38 | 2016-07-18 | ARDX | Ardelyx Inc. | BARRETT M JAMES | 10% owner | Pharmaceutical Preparations | BUY | $8.73 | 763,650 | $6,666,665 | 8,752,543 | +9.6% |
| 2016-07-20 23:38 | 2016-07-18 | ARDX | Ardelyx Inc. | BARRIS PETER J | 10% owner | Pharmaceutical Preparations | BUY | $8.73 | 2,290,951 | $20,000,002 | 2,665,519 | +611.6% |
| 2016-07-20 02:27 | 2016-07-18 | LNG | Cheniere Energy, Inc. | Fusco Jack A | Director, Officer - President and CEO | Natural Gas Distribution | BUY | $39.89 | 37,604 | $1,499,945 | 69,798 | +116.8% |
| 2016-07-20 01:54 | 2016-07-15 | DRII | N/A | GUGGENHEIM CAPITAL LLC | 10% owner | Other | BUY | $30.14 | 1,260,008 | $37,976,641 | 7,685,089 | +19.6% |
| 2016-07-20 00:45 | 2016-07-15 | CONN | N/A | WARREN A STEPHENS GRANTORS TRUST | 10% owner | Other | BUY | $7.10 | 285,000 | $2,023,500 | 385,350 | +284.0% |
| 2016-07-20 00:46 | 2016-07-15 | CONN | N/A | STEPHENS HARRIET C | 10% owner | Other | BUY | $7.10 | 1,000,000 | $7,100,000 | 430,000 | +100.0% |
| 2016-07-20 00:47 | 2016-07-15 | CONN | N/A | STEPHENS WARREN A | 10% owner | Other | BUY | $7.10 | 1,000,000 | $7,100,000 | 430,000 | +100.0% |
| 2016-07-19 23:40 | 2016-07-15 | OSTK | BED BATH & BEYOND, INC. | Simon Stormy | Director, Officer - President | Retail-Catalog & Mail-Order Houses | BUY | $16.96 | 70,000 | $1,187,200 | 147,417 | +90.4% |
| 2016-07-14 21:33 | 2016-07-12 | N/A | NEXPOINT REAL ESTATE STRATEGIES FUND | DONDERO JAMES D | Officer, 10% owner - See Remarks | Other | BUY | $20.00 | 50,150 | $1,003,009 | 50,150 | +100.0% |
| 2016-07-13 23:01 | 2016-07-12 | MIIIU | N/A | Meghji Mohsin Y | Director, Officer, 10% owner - See Remarks | Other | BUY | $10.00 | 340,000 | $3,400,000 | 4,612,500 | +8.0% |
| 2016-07-13 23:01 | 2016-06-27 | WWWW | N/A | Okumus Fund Management Ltd. | 10% owner | Other | BUY | $16.92 | 709,767 | $12,005,709 | 9,560,033 | +8.0% |
| 2016-07-12 02:03 | 2016-07-07 | CIGI | Colliers International Group Inc. | SPRUCE HOUSE PARTNERSHIP LP | 10% owner | Real Estate | BUY | $34.60 | 266,288 | $9,214,097 | 4,132,351 | +6.9% |
| 2016-07-08 17:44 | 2016-07-06 | SEV | N/A | Meson Constructive Capital LP | 10% owner | Other | BUY | $9.12 | 614,000 | $5,599,680 | 614,000 | +100.0% |
| 2016-07-08 17:32 | 2016-07-06 | SEV | N/A | Morris Ryan J. | Director | Other | BUY | $9.12 | 669,000 | $6,101,280 | 614,000 | +100.0% |
| 2016-07-08 22:08 | 2016-07-05 | RSE | N/A | Brookfield Property Partners Ltd | 10% owner | Other | BUY | $18.25 | 57,887,442 | $1,056,445,817 | 333 | +100.0% |
| 2016-07-08 00:41 | 2016-07-06 | SYRS | Syros Pharmaceuticals Inc. | Nashat Amir | Director, 10% owner | Pharmaceutical Preparations | BUY | $12.50 | 400,000 | $5,000,000 | 48,320 | +100.0% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.